Jeremy Chan
Papers
1
Total Citations
44
H-Index
1
About
Jeremy Chan is a leading surgical oncologist whose research focuses on advancing minimally invasive techniques for complex hepatopancreatobiliary (HPB) cancers. His key contributions center on evaluating the safety, efficacy, and therapeutic value of robotic surgery for high-risk procedures such as pancreaticoduodenectomy (PD). In his highly cited 2022 systematic review, Chan systematically compared robotic versus open PD, demonstrating that robotic approaches can improve dexterity, visibility, and clinical outcomes while maintaining comparable therapeutic indexes. This work, with 44 citations, has helped shape the evidence base for adopting robotic platforms in challenging HPB surgeries. Beyond this, Chan’s broader research portfolio explores peri-operative optimization, surgical quality metrics, and oncologic outcomes in pancreatic and liver malignancies. His work is widely referenced by surgeons and researchers seeking to integrate robotic techniques into practice while ensuring patient safety. Chan’s contributions have positioned him as a key voice in the transition toward precision, minimally invasive cancer surgery, with his findings informing both clinical guidelines and future trial design.
Research Focus
Key Achievements
Top Papers
- 1